Drug Approvals

FDA Approval Tarzenta: Accelerated Approval for Advanced HER2-Negative Breast Cancer

FDA · breast cancer · 7 min

FDA Approves Ritempro: New Parkinson's Disease Motor Fluctuations Treatment

FDA · Parkinson's disease · 4 min

FDA Approves Tevimbra: Breakthrough for Esophageal Squamous Cell Carcinoma

FDA · Esophageal Squamous Cell Carcinoma · 5 min

FDA Approves Wainua: AstraZeneca's Eplontersen for hATTR-PN

FDA · Hereditary transthyretin-mediated amyloid polyneuropathy · 4 min

FDA Approves Altuviiio: Sanofi's Long-Acting Hemophilia A Therapy

FDA · Hemophilia A · 4 min

FDA Approves Augtyro: Bristol Myers Squibb’s Repotrectinib for ROS1-NSCLC

FDA · Non-Small Cell Lung Cancer · 4 min

FDA Approves Repatha for Pediatric Heterozygous Familial Hypercholesterolemia

FDA · cardiology · 4 min

FDA Approves Adzynma: New Treatment for Thrombotic Thrombocytopenic Purpura

FDA · Hematology · 6 min

FDA Approves Veozah: New Non-Hormonal Menopause Treatment

FDA · Menopause · 4 min

FDA Approves Omisirge: New Allogeneic Stem Cell Therapy for Hematologic Cancers

FDA · hematologic malignancies · 4 min

FDA Approves Updated COVID-19 Vaccines for Fall 2024

FDA · Infectious Disease · 4 min

FDA Approves Bosulif for Pediatric Chronic Myelogenous Leukemia

FDA · chronic myelogenous leukemia · 7 min